Ascentage Pharma Group International
NASDAQ:AAPG · NASDAQ Global Market
+$0.31 today
Vol 0.01M · Avg 0.01M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-53.92%
Period High
$47.90
Period Low
$17.01
Latest
$17.12
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Centessa Pharmaceuticals plc
NASDAQ:CNTA
$6.17B
Apogee Therapeutics, Inc.
NASDAQ:APGE
$5.44B
CG Oncology, Inc. Common stock
NASDAQ:CGON
$5.35B
Legend Biotech Corporation
NASDAQ:LEGN
$5.34B
Celcuity Inc.
NASDAQ:CELC
$4.20B
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$4.17B
Soleno Therapeutics, Inc.
SLNO
$2.76B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.72B
Disc Medicine, Inc.
NASDAQ:IRON
$2.68B
Zai Lab Limited
NASDAQ:ZLAB
$2.06B
What is the latest AAPG filing?
The latest filing shown is 6-K dated Jun 15, 2026.
How many recent filings does AAPG have?
Intrinsic Alpha currently shows 20 recent filings for AAPG.
Explore More
Continue the stock analysis
Jump to another research area for this company.